The project combined expertise in toxinology, antibody engineering, and protein science. Researchers at the Indian Institute of Science (IISc), Bengaluru, in collaboration with the Technical ...

Every September, Australians are encouraged to ask someone a simple question: “Are you OK?” R U OK? Day is Australia’s most recognisable mental health campaign, and a familiar part of workplace ...

Исследователи из Университета Тулейна, Стэнфорда и CDC обнаружили у рукокрылых семейства вечерниц (Vespertilionidae) две разные копии генов ...

Исследователи обнаружили у рукокрылых семейства Vespertilionidae (вечерних летучих мышей) вторую систему генов, отвечающую за выработку антител.

Antibody-drug conjugates (ADCs) have emerged as one of the most impactful therapeutic advances in modern oncology, fundamentally reshaping the treatment landscape across both hematologic malignancies ...

PHILADELPHIA — The investigational drug verekitug improved sinonasal symptoms, reduced nasal polyp size, and reduced the need for nasal polyp surgery in people with chronic rhinosinusitis with nasal ...

Research led by the University of Washington reports on an AI-guided method that designs epitope-specific antibodies and confirms atomically precise binding using high-resolution molecular imaging, ...

A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the role of B cells and self-reactive antibodies in lupus, systemic sclerosis, ...

Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...

A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments SEATTLE — July 23, 2025 — A landmark study has ...

Monoclonal antibodies (mAbs) make up one of the most important classes of advanced biotherapies. To find out about the current challenges and advances in the production of mAbs, GEN talked with Lukas ...

Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss—No Target Is Out of the Realm of Possibility Bispecific antibodies (bsAbs) have emerged as a novel ...